The Chemours Company (CC)
$
13.14
+0.08 (0.61%)
Key metrics
Financial statements
Free cash flow per share
0.0467
Market cap
2 Billion
Price to sales ratio
0.3332
Debt to equity
0.8557
Current ratio
1.7059
Income quality
-0.7982
Average inventory
1.6 Billion
ROE
-0.7753
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
The Chemours Company, founded in 2014 and headquartered in Wilmington, Delaware, provides performance chemicals across several global regions, including North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment specializes in TiO2 pigment under the Ti-Pure and BaiMax brands, which deliver essential properties such as whiteness, brightness, opacity, and protection across a range of applications, including architectural and industrial coatings, plastic packaging, and laminate papers. The Thermal & Specialized Solutions segment focuses on refrigerants, thermal management solutions, and foam blowing agents, while the Advanced Performance Materials portfolio contains industrial resins, specialty products, and coatings for various sectors, including consumer electronics and semiconductors. The Chemical Solutions segment offers industrial chemicals vital for multiple uses, such as gold production and water treatment. The company recorded an operating income of $443,000,000.00 reflecting its earnings from core operations. The weighted average number of shares outstanding is $149,494,000.00 highlighting the company's shareholder base. The financial data pertains to the fiscal year $2024 with operating expenses amounting to $708,000,000.00 showcasing the various costs incurred in operations. Additionally, the company earned an interest income of $0.00 illustrating its financial investments in diverse areas. In the investment landscape, the company's stock is affordable at $17.01 making it a suitable option for budget-conscious investors. It features a high average trading volume of 2,937,507.00 indicating strong liquidity that can support active trading strategies. With a mid-range market capitalization of $1,969,393,635.00 the company exemplifies steady performance within its sector. It is a key player in the Chemicals - Specialty industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Basic Materials sector, driving innovation and growth, which presents prospects for future developments that investors may find appealing.
Is The Chemours Company (CC) a good investment?
Investing in The Chemours Company (CC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as D+, with a Bullish outlook. Always conduct your own research before investing.
What is The Chemours Company (CC)'s stock forecast?
Analysts predict The Chemours Company stock to fluctuate between $9.13 (low) and $20.12 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is The Chemours Company's market capitalization?
As of 2025-12-11, The Chemours Company's market cap is $1,969,393,635, based on 149,877,750 outstanding shares.
How does The Chemours Company compare to competitors like Southern Copper Corporation?
Compared to Southern Copper Corporation, The Chemours Company has a Lower Market-Cap, indicating a difference in performance.
Does The Chemours Company pay dividends?
The Chemours Company pays dividends. The current dividend yield is 4.31%, with a payout of $0.09 per share.
How can I buy The Chemours Company (CC) stock?
To buy The Chemours Company (CC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CC. Place an order (Market, Limit, etc.).
What is the best time to invest in The Chemours Company?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did The Chemours Company perform in the last earnings report?
Revenue: $5,782,000,000 | EPS: $0.58 | Growth: -136.25%.
Where can I find The Chemours Company's investor relations reports?
Visit https://www.chemours.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for The Chemours Company?
You can explore historical data from here
What is the all-time high and low for The Chemours Company stock?
All-time high: $44.95 (2022-06-06) | All-time low: $9.13 (2025-06-02).
What are the key trends affecting The Chemours Company stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
businesswire.com
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel.
fool.com
New York City-based Cooper Creek Partners bought nearly 4 million shares of The Chemours Company in the third quarter. The shares were worth about $63.1 million at the end of the quarter.
seekingalpha.com
Chemours remains challenged by weak end markets, but progress on environmental liabilities and Opteon growth support medium-term prospects. Q3 results were mixed, with disruptions impacting earnings, but the resolution of outages and Opteon gains in the TSS segment provide optimism for improvement. TT segment struggles with weak construction activity, but price increases and supply rationalization should help results bottom in 6–9 months.
seekingalpha.com
The Chemours Company ( CC ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director Shane Hostetter - Senior VP & CFO Conference Call Participants John McNulty - BMO Capital Markets Equity Research Peter Osterland - Truist Securities, Inc., Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Arun Viswanathan - RBC Capital Markets, Research Division Joshua Spector - UBS Investment Bank, Research Division Patrick Fischer - Goldman Sachs Group, Inc., Research Division Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies LLC, Research Division Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division Vincent Andrews - Morgan Stanley, Research Division Roger Spitz - BofA Securities, Research Division Aaron Rosenthal - JPMorgan Chase & Co, Research Division Presentation Operator Good morning. My name is Gigi, and I'll be your conference operator today.
barrons.com
Earnings were light, driven by slowing sales of titanium dioxide, a key component of white paint.
zacks.com
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zacks.com
Chemours (CC) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.4 per share a year ago.
businesswire.com
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Third Quarter 2025 Results.
businesswire.com
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call.
fool.com
Luminus Management LLC reduced its stake in The Chemours Company (CC -1.86%) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC filing dated October 3, 2025.
See all news
